Trial intelligence / Profile preview

Pulpotomy with formocresol, calcium enriched mixture cement, and sodium hypochlorite 5%

IRCT2013092414749N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Nov 2012
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of formocresol, Calcium Enriched Mixture cement and sodium hypochlorite in pulpitis (3 arms), sponsored by Isfahan University of Medical Sciences. Started Nov 2012; status: completed.

02

Drugs

formocresolCalcium Enriched Mixture cementsodium hypochlorite
03

Conditions

pulpitis

Beyond the preview

Go deeper on IRCT2013092414749N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2013092414749N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call